Amyloidosis: is a cure possible?
Amyloidosis Center, Fondazione IRCCS Policlinico San Matteo-University of Pavia, Pavia, Italy.
G
G
Merlini
G
G
Palladini
D000686:Amyloidosis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D003907:Dexamethasone / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D033581:Stem Cell Transplantation; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D015415:Biomarkers; D003907:Dexamethasone; D008558:Melphalan